Drug & intervention

pramlintide

RxCUI 139953

Clinical trials12
Recruiting0
Related conditions9
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Pramlintide

Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt.

Read on Wikipedia ↗ Wikidata Q2062094 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

12 shown
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesNCT06046417 · 2023-11-30
UNKNOWN
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesNCT05199714 · 2022-02-21
COMPLETED
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes MellitusNCT01137695 · 2010-05-01
UNKNOWN
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes MellitusNCT01165944 · 2009-08-01
WITHDRAWN
Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaNCT01269047 · 2009-08-01
COMPLETED
Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaNCT00690235 · 2007-11-01
COMPLETED
The Effect of Pramlintide on Meal Time Insulin BolusNCT00460304 · 2007-09-01
COMPLETED
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesNCT00505882 · 2007-07-01
WITHDRAWN
Pramlintide in Adolescents With Type 1 DiabetesNCT00842075 · 2006-12-01
COMPLETED
Continuous Subcutaneous Infusion of Pramlintide and InsulinNCT00291772 · 2006-01-01
COMPLETED
Effect of Hyperglycemia on Gastric Emptying Interactions With PramlintideNCT00489645 · 2005-01-01
COMPLETED
The Effect of Prolonged Pramlintide Infusion in Pediatric DiabetesNCT00206297 · 2003-10-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.